These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23580565)

  • 21. Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
    Escrig JI; Miyamoto Y; Aznar AD; Eckmann L; Debnath A
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0073123. PubMed ID: 38063401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.
    Galkin A; Kulakova L; Lim K; Chen CZ; Zheng W; Turko IV; Herzberg O
    J Biol Chem; 2014 Apr; 289(15):10502-10509. PubMed ID: 24558036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of nitro-heterocyclic compounds on Escherichia coli.
    Hof H; Chakraborty T; Royer R; Buisson JP
    Drugs Exp Clin Res; 1987; 13(10):635-9. PubMed ID: 3322751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia.
    Leitsch D; Burgess AG; Dunn LA; Krauer KG; Tan K; Duchêne M; Upcroft P; Eckmann L; Upcroft JA
    J Antimicrob Chemother; 2011 Aug; 66(8):1756-65. PubMed ID: 21602576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of PFOR gene expression in strains of G. intestinalis with different inhibitory concentrations of metronidazole.
    Begaydarova R; Yukhnevich Y; Babenko D; Kaliyeva S; Azizov I; Muldaeva G; Omarkulov B
    J Infect Dev Ctries; 2015 May; 9(5):519-23. PubMed ID: 25989172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of housekeeping genes as an internal control for gene expression studies in Giardia lamblia using quantitative real-time PCR.
    Marcial-Quino J; Fierro F; De la Mora-De la Mora I; Enríquez-Flores S; Gómez-Manzo S; Vanoye-Carlo A; Garcia-Torres I; Sierra-Palacios E; Reyes-Vivas H
    Gene; 2016 Apr; 581(1):21-30. PubMed ID: 26778241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts.
    Bernal-Redondo R; Martínez-Méndez LG; Mendoza-Chavez A; Velasco-Perales D; Chavez-Munguia B
    J Submicrosc Cytol Pathol; 2004; 36(3-4):241-5. PubMed ID: 15906598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis.
    Navarrete-Vázquez G; Chávez-Silva F; Colín-Lozano B; Estrada-Soto S; Hidalgo-Figueroa S; Guerrero-Álvarez J; Méndez ST; Reyes-Vivas H; Oria-Hernández J; Canul-Canché J; Ortiz-Andrade R; Moo-Puc R
    Bioorg Med Chem; 2015 May; 23(9):2204-10. PubMed ID: 25801157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells.
    Müller J; Rühle G; Müller N; Rossignol JF; Hemphill A
    Antimicrob Agents Chemother; 2006 Jan; 50(1):162-70. PubMed ID: 16377682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
    Abboud P; Lemée V; Gargala G; Brasseur P; Ballet JJ; Borsa-Lebas F; Caron F; Favennec L
    Clin Infect Dis; 2001 Jun; 32(12):1792-4. PubMed ID: 11360222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of the in vitro activity of a Nitazoxanide-N-methyl-1H-benzimidazole hybrid molecule against albendazole and nitazoxanide susceptible and resistant strains of Giardia intestinalis and its in vivo giardicidal activity.
    Matadamas-Martínez F; Nogueda-Torres B; Castillo R; Hernández-Campos A; Barrera-Valdes ML; León-Ávila G; Hernández JM; Yépez-Mulia L
    Mem Inst Oswaldo Cruz; 2020; 115():e190348. PubMed ID: 32049098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide.
    Ángeles-Arvizu A; Enriquez-Flores S; Jiménez-Gutiérrez A; Pérez-Rangel A; Luna-Arias JP; Castillo-Romero A; Hernández JM; León-Avila G
    Acta Parasitol; 2021 Dec; 66(4):1158-1166. PubMed ID: 33840056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
    Lalle M
    Infect Disord Drug Targets; 2010 Aug; 10(4):283-94. PubMed ID: 20429863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Validation of Small-Gatekeeper Kinases as Drug Targets in Giardia lamblia.
    Hennessey KM; Smith TR; Xu JW; Alas GC; Ojo KK; Merritt EA; Paredez AR
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005107. PubMed ID: 27806042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic and ultrastructural analysis of the effect of a new nitazoxanide-N-methyl-1H-benzimidazole hybrid against Giardia intestinalis.
    Matadamas-Martínez F; Castillo R; Hernández-Campos A; Méndez-Cuesta C; de Souza W; Gadelha AP; Nogueda-Torres B; Hernández JM; Yépez-Mulia L
    Res Vet Sci; 2016 Apr; 105():171-9. PubMed ID: 27033928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel antigiardiasis drug candidates.
    Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
    Tejman-Yarden N; Millman M; Lauwaet T; Davids BJ; Gillin FD; Dunn L; Upcroft JA; Miyamoto Y; Eckmann L
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4643-51. PubMed ID: 21825286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning, Expression and Characterization of Recombinant, NADH Oxidase from Giardia lamblia.
    Castillo-Villanueva A; Méndez ST; Torres-Arroyo A; Reyes-Vivas H; Oria-Hernández J
    Protein J; 2016 Feb; 35(1):24-33. PubMed ID: 26685698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.
    Busatti HG; Alves RJ; Santana-Anjos KG; Gil FF; Cury MC; Vannier-Santos MA; Gomes MA
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):160-4. PubMed ID: 23331963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent Transcriptional Responses to Physiological and Xenobiotic Stress in Giardia duodenalis.
    Ansell BR; McConville MJ; Baker L; Korhonen PK; Emery SJ; Svärd SG; Gasser RB; Jex AR
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6034-45. PubMed ID: 27458219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.